Myopathy and spontaneous Pasteurella pneumotropica-induced abscess formation in an HIV-1 transgenic mouse model.
In an effort to augment human immunodeficiency virus type 1 (HIV-1) gene expression in transgenic mice, an infectious proviral DNA clone was modified by deleting the two NF kappa B binding sites and some adjacent upstream LTR sequences and replacing them with the core enhancer of Moloney murine leukemia virus (MLV). Two independent lines of MLV/HIV transgenic mice were established that expressed HIV-1-specific RNA in lymphoid tissue, striated skeletal muscle, and the eye lens. Heterozygous animals from each transgenic line spontaneously developed an inflammatory disease of the eye associated with the production of copious amounts of purulent lacrimal secretions beginning at 2 weeks of age. Periorbital abscess formation became grossly apparent by 2 months of age and Pasteurella pneumotropica was cultured from the harderian glands and conjunctival surfaces of many of the MLV/HIV animals but not their nontransgenic, cohabiting littermates. This gram-negative commensal bacterium has been previously associated with a similar disease phenotype in immunocompromised (e.g., nude mice) rodent colonies. MLV/HIV mice developed normally until 15 weeks of age, when weight loss and wasting occurred, culminating in premature death (as earlier as 6 months of age). The cachexia was associated with an initially focal and subsequently progressive myopathy, coinciding with age-related increases of HIV gene expression in muscle.
Dickie
P
P
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Mounts
P
P
Purcell
D
D
Miller
G
G
Fredrickson
T
T
Chang
L J
LJ
Martin
M A
MA
D000038:Abscess / Q000382:microbiology*; D000818:Animals; D003001:Cloning, Molecular; D005123:Eye / Q000821:virology; D005128:Eye Diseases / Q000382:microbiology*; D005434:Flow Cytometry; D015967:Gene Expression Regulation, Viral; D015658:HIV Infections / Q000150:complications* / Q000235:genetics*; D019247:HIV Wasting Syndrome / Q000821:virology; D015497:HIV-1; D007136:Immunoglobulins / Q000032:analysis; D007150:Immunohistochemistry; D008198:Lymph Nodes / Q000821:virology; D008213:Lymphocyte Activation; D051379:Mice; D008822:Mice, Transgenic / Q000821:virology*; D008979:Moloney murine leukemia virus / Q000235:genetics; D018482:Muscle, Skeletal / Q000821:virology; D009135:Muscular Diseases / Q000821:virology*; D016254:Mutagenesis, Insertional; D009210:Myofibrils / Q000473:pathology; D010326:Pasteurella Infections / Q000382:microbiology*; D011533:Proviruses / Q000235:genetics; D012367:RNA, Viral / Q000302:isolation & purification; D017384:Sequence Deletion; D013154:Spleen / Q000821:virology; D013601:T-Lymphocytes / Q000821:virology
D007136:Immunoglobulins; D012367:RNA, Viral